Discover the future of digital pathology at our exclusive webinar, featuring the launch of 'Foresight' within Patholytix 4.0. This revolutionary AI decision support tool, a collaboration between Deciphex and Charles River Laboratories, signifies a transformative step in nonclinical pathology. Foresight integrates advanced AI with Whole Slide Images (WSI) to enhance decision-making in drug discovery and early safety assessment. Augmenting digital pathology evaluations with Foresight will provide a pathologist with simple and visual tools to facilitate efficiency, consistency, and accuracy in their work.
In this session, Dr. Daniel G. Rudmann from Charles River Laboratories will unveil Foresight, showcasing its integration in Patholytix. A panel of renowned pathologists and AI specialists from Deciphex and Charles River will discuss Foresight's development, capabilities, and future potential. They'll delve into its specific application in Discovery and Lead Optimization Toxicology (LOT) Rodent studies across seven key tissues, demonstrating its potential utility in multiple settings for pathologists. They will also discuss the roadmap for future enhancements.
When
On-demand
Speakers
Dr. Dan Rudmann
Senior Director of Global Digital Toxicologic Pathology at Charles River Laboratories
Dr. Dan Rudmann is a distinguished preclinical Research and Development executive with an extensive career spanning over 25 years in the pharmaceutical and Contract Research Organization (CRO) industries. Board certified by the American College of Veterinary Pathologists (ACVP) as an anatomic toxicologic pathologist, Dr. Rudmann possesses a robust educational foundation, underscored by his PhD training. His expertise extends into managing toxicology and clinical programs, where he leverages his knowledge to advance scientific discoveries and therapeutic developments.
Dr. Rudmann is internationally recognized as a global thought leader in the realms of Digital Toxicologic Pathology and the application of Deep Learning-based decision support systems. His work in these areas not only highlights his innovative approach to pathology but also his commitment to integrating cutting-edge technologies into traditional practices to enhance decision-making processes.
The webinar will be accessible on-demand for those who register, ensuring you can view it at your convenience, should the live session's timing not align with your time zone. Please register to gain access to the on-demand webinar.
Moderator
Colin Doolan
VP Business Development, Research Pathology
Colin has almost 20 years of experience focused on the delivery of innovative digital pathology software & services to Academic, Research and Clinical markets. He has worked in both Start-Up and Large Corporate environments, fulfilling a broad remit of customer-facing roles in Business Development, Sales, Commercial Marketing and Strategic Product Management.
Panelists
Dr. Aleksandra Zuraw
Veterinary Pathologist at CRL
Dr. Aleksandra Zuraw is a pioneering veterinary pathologist specializing in digital pathology. She champions the integration of cutting-edge digital tools into veterinary medicine, leveraging her expertise to advance diagnostics and research. Through her influential online presence on Digital Pathology Place and social media, Dr. Zuraw promotes the benefits of digital pathology, inspiring collaboration and innovation worldwide. Her dedication and leadership have established her as a prominent figure in the field, shaping the future of veterinary pathology.
Jogile Kuklyte
Commercial AI Projects Manager at Deciphex
Jogile Kuklyte embarked on her journey in Artificial Intelligence during her PhD, focusing on unusual event detection in live-stream surveillance cameras. While still in academia, she also taught software development and engineering. In the industry, she has worked on image and video analysis applications in the entertainment, security, and health sectors. For the past few years at Deciphex, she has been leading a Commercial AI Research team, developing AI-based solutions for non-clinical applications in a commercial environment.
Laoise Lord Bissett
Product Applications Manager, Research Pathology at Deciphex
Laoise Lord Bissett has a background in biomedical science and had worked for the last number of years on the CRL-Deciphex AI collaboration in the capacity of AI project manager on Jogile’s team, and is now currently working in the role of Product Applications Manager to bring Foresight and other AI tools to the wider pathology audience.
Lise Bertrand
Scientific Director Digital Pathology ∓ Europe Digital Pathology Lead at CRL
Lise has worked in industry for 13 years and is currently a Scientific Director in Digital Pathology and Europe Digital Pathology Lead for Charles River. She is also the Digital Pathology councilor of the European Society of Toxicologic Pathology.
Thank you! Your article will be revealed in a matter of seconds
Oops! Something went wrong while submitting the form.
Discover the future of digital pathology at our exclusive webinar, featuring the launch of 'Foresight' within Patholytix 4.0. This revolutionary AI decision support tool, a collaboration between Deciphex and Charles River Laboratories, signifies a transformative step in nonclinical pathology. Foresight integrates advanced AI with Whole Slide Images (WSI) to enhance decision-making in drug discovery and early safety assessment. Augmenting digital pathology evaluations with Foresight will provide a pathologist with simple and visual tools to facilitate efficiency, consistency, and accuracy in their work.
In this session, Dr. Daniel G. Rudmann from Charles River Laboratories will unveil Foresight, showcasing its integration in Patholytix. A panel of renowned pathologists and AI specialists from Deciphex and Charles River will discuss Foresight's development, capabilities, and future potential. They'll delve into its specific application in Discovery and Lead Optimization Toxicology (LOT) Rodent studies across seven key tissues, demonstrating its potential utility in multiple settings for pathologists. They will also discuss the roadmap for future enhancements.
When
On-demand
Speakers
Dr. Dan Rudmann
Senior Director of Global Digital Toxicologic Pathology at Charles River Laboratories
Dr. Dan Rudmann is a distinguished preclinical Research and Development executive with an extensive career spanning over 25 years in the pharmaceutical and Contract Research Organization (CRO) industries. Board certified by the American College of Veterinary Pathologists (ACVP) as an anatomic toxicologic pathologist, Dr. Rudmann possesses a robust educational foundation, underscored by his PhD training. His expertise extends into managing toxicology and clinical programs, where he leverages his knowledge to advance scientific discoveries and therapeutic developments.
Dr. Rudmann is internationally recognized as a global thought leader in the realms of Digital Toxicologic Pathology and the application of Deep Learning-based decision support systems. His work in these areas not only highlights his innovative approach to pathology but also his commitment to integrating cutting-edge technologies into traditional practices to enhance decision-making processes.
The webinar will be accessible on-demand for those who register, ensuring you can view it at your convenience, should the live session's timing not align with your time zone. Please register to gain access to the on-demand webinar.
Moderator
Colin Doolan
VP Business Development, Research Pathology
Colin has almost 20 years of experience focused on the delivery of innovative digital pathology software & services to Academic, Research and Clinical markets. He has worked in both Start-Up and Large Corporate environments, fulfilling a broad remit of customer-facing roles in Business Development, Sales, Commercial Marketing and Strategic Product Management.
Panelists
Dr. Aleksandra Zuraw
Veterinary Pathologist at CRL
Dr. Aleksandra Zuraw is a pioneering veterinary pathologist specializing in digital pathology. She champions the integration of cutting-edge digital tools into veterinary medicine, leveraging her expertise to advance diagnostics and research. Through her influential online presence on Digital Pathology Place and social media, Dr. Zuraw promotes the benefits of digital pathology, inspiring collaboration and innovation worldwide. Her dedication and leadership have established her as a prominent figure in the field, shaping the future of veterinary pathology.
Jogile Kuklyte
Commercial AI Projects Manager at Deciphex
Jogile Kuklyte embarked on her journey in Artificial Intelligence during her PhD, focusing on unusual event detection in live-stream surveillance cameras. While still in academia, she also taught software development and engineering. In the industry, she has worked on image and video analysis applications in the entertainment, security, and health sectors. For the past few years at Deciphex, she has been leading a Commercial AI Research team, developing AI-based solutions for non-clinical applications in a commercial environment.
Laoise Lord Bissett
Product Applications Manager, Research Pathology at Deciphex
Laoise Lord Bissett has a background in biomedical science and had worked for the last number of years on the CRL-Deciphex AI collaboration in the capacity of AI project manager on Jogile’s team, and is now currently working in the role of Product Applications Manager to bring Foresight and other AI tools to the wider pathology audience.
Lise Bertrand
Scientific Director Digital Pathology ∓ Europe Digital Pathology Lead at CRL
Lise has worked in industry for 13 years and is currently a Scientific Director in Digital Pathology and Europe Digital Pathology Lead for Charles River. She is also the Digital Pathology councilor of the European Society of Toxicologic Pathology.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
